Literature DB >> 15677560

Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.

Ursula Hainz1, Petra Obexer, Christiana Winkler, Peter Sedlmayr, Osamu Takikawa, Hildegard Greinix, Anita Lawitschka, Ulrike Pötschger, Dietmar Fuchs, Stephan Ladisch, Andreas Heitger.   

Abstract

T-cell dysfunction after human hematopoietic stem-cell transplantation (HSCT) is generally attributed to intrinsic T-cell defects. Here we show that the characteristic impaired proliferative responses to polyclonal stimulation of post-HSCT peripheral blood mononuclear cells (PB-MCs) were markedly (4-fold) improved by T-cell enrichment. Conversely, addback of post-HSCT monocytes to these enriched T cells dampened their proliferative responses, suggesting that post-HSCT monocytes effectively mediate T-cell suppression. As a mechanism possibly contributing to monocyte-mediated T-cell suppression, we investigated monocyte tryptophan catabolism by indoleamine 2,3-dioxygenase into kynurenine, which has been implicated in regulating T-cell responses. Compared with controls, all post-HSCT monocyte-containing cell cultures (total PBMCs, monocytes, and monocyte/T-cell cocultures), but not monocyte-depleted populations, secreted elevated amounts of kynurenine. Blockade of tryptophan catabolism improved the proliferative responses. The slightly increased kynurenine release and substantial release of neopterin by unstimulated post-HSCT monocytes suggests that they were in a state of continuous activation. Superimposed on this state, stimulation of these cells caused a striking, additional increase (10-fold) in kynurenine release, and they triggered marked apoptosis of autologous post-HSCT T cells. We conclude that the amplified kynurenine release by post-HSCT monocytes, particularly induced upon stimulation, may underlie their suppressor activity, which in turn may contribute to the depressed T-cell immune responses after HSCT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15677560      PMCID: PMC1895091          DOI: 10.1182/blood-2004-05-1726

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  64 in total

1.  G-CSF reduces IFN-gamma and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function.

Authors:  Y Nawa; T Teshima; K Sunami; Y Hiramatsu; Y Maeda; T Yano; K Shinagawa; F Ishimaru; E Omoto; M Harada
Journal:  Bone Marrow Transplant       Date:  2000-05       Impact factor: 5.483

2.  Immune dysfunction despite high levels of immunoregulatory cytokine gene expression in autologous peripheral blood stem cell transplanted non-Hodgkin's lymphoma patients.

Authors:  R K Singh; M L Varney; K Ino; J M Vose; P J Bierman; J E Talmadge
Journal:  Exp Hematol       Date:  2000-05       Impact factor: 3.084

3.  T-Cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires.

Authors:  B C Godthelp; M J van Tol; J M Vossen; P J van Den Elsen
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

Review 4.  Neopterin production, tryptophan degradation, and mental depression--what is the link?

Authors:  Bernhard Widner; Andreas Laich; Barbara Sperner-Unterweger; Maximilian Ledochowski; Dietmar Fuchs
Journal:  Brain Behav Immun       Date:  2002-10       Impact factor: 7.217

5.  Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism.

Authors:  S Fujigaki; K Saito; K Sekikawa; S Tone; O Takikawa; H Fujii; H Wada; A Noma; M Seishima
Journal:  Eur J Immunol       Date:  2001-08       Impact factor: 5.532

6.  Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell-depleted stem cell transplantation.

Authors:  A E Broers; R van Der Holt; J W van Esser; J W Gratama; S Henzen-Logmans; V Kuenen-Boumeester; B Löwenberg; J J Cornelissen
Journal:  Blood       Date:  2000-04-01       Impact factor: 22.113

7.  Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.

Authors:  Neide M Silva; Cibele V Rodrigues; Marcelo M Santoro; Luiz F L Reis; Jacqueline I Alvarez-Leite; Ricardo T Gazzinelli
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

8.  Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer.

Authors:  D Avigan; Z Wu; R Joyce; A Elias; P Richardson; D McDermott; J Levine; L Kennedy; N Giallombardo; D Hurley; J Gong; D Kufe
Journal:  Bone Marrow Transplant       Date:  2000-07       Impact factor: 5.483

9.  Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation.

Authors:  P Hwu; M X Du; R Lapointe; M Do; M W Taylor; H A Young
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

10.  Antioxidants inhibit indoleamine 2,3-dioxygenase in IFN-gamma-activated human macrophages: posttranslational regulation by pyrrolidine dithiocarbamate.

Authors:  S R Thomas; H Salahifar; R Mashima; N H Hunt; D R Richardson; R Stocker
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

View more
  10 in total

1.  Low Level Donor Chimerism of CD19 CAR-T Cells Returned to Complete Donor Chimerism in Patients with Relapse After Allo-Hematopoietic Stem Cell Transplant.

Authors:  Qing Li; Juan Mu; Jijun Yuan; Zhenxing Yang; Jia Wang; Qi Deng
Journal:  Onco Targets Ther       Date:  2020-11-09       Impact factor: 4.147

Review 2.  Is IDO a key enzyme bridging the gap between tumor escape and tolerance induction?

Authors:  Stefan Löb; Alfred Königsrainer
Journal:  Langenbecks Arch Surg       Date:  2007-12-04       Impact factor: 3.445

3.  Granulocyte colony-stimulating factor-induced immature myeloid cells inhibit acute graft-versus-host disease lethality through an indoleamine dioxygenase-independent mechanism.

Authors:  Young-Don Joo; Sun-Mi Lee; Soo-Woong Lee; Won-Sik Lee; Sang-Min Lee; Ji-Kyoung Park; Il-Whan Choi; Sae-Gwang Park; Inhak Choi; Su-Kil Seo
Journal:  Immunology       Date:  2009-01-12       Impact factor: 7.397

4.  IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Ig-mediated long-term solid organ allograft survival.

Authors:  Robert Sucher; Klaus Fischler; Rupert Oberhuber; Irmgard Kronberger; Christian Margreiter; Robert Ollinger; Stefan Schneeberger; Dietmar Fuchs; Ernst R Werner; Katrin Watschinger; Bettina Zelger; George Tellides; Nina Pilat; Johann Pratschke; Raimund Margreiter; Thomas Wekerle; Gerald Brandacher
Journal:  J Immunol       Date:  2011-11-30       Impact factor: 5.422

5.  Indoleamine 2,3-dioxygenase in human hematopoietic stem cell transplantation.

Authors:  Birgit Jürgens; Julia Raberger; Dietmar Fuchs; Andreas Heitger
Journal:  Int J Tryptophan Res       Date:  2010-06-10

Review 6.  The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation.

Authors:  N H Servaas; J Spierings; A Pandit; J M van Laar
Journal:  Clin Exp Immunol       Date:  2020-02-17       Impact factor: 4.330

Review 7.  Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis.

Authors:  Marianna Y Kawashima-Vasconcelos; Maynara Santana-Gonçalves; Djúlio C Zanin-Silva; Kelen C R Malmegrim; Maria Carolina Oliveira
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

Review 8.  The kynurenine pathway in stem cell biology.

Authors:  Simon P Jones; Gilles J Guillemin; Bruce J Brew
Journal:  Int J Tryptophan Res       Date:  2013-09-15

9.  Mobilization of healthy donors with plerixafor affects the cellular composition of T-cell receptor (TCR)-αβ/CD19-depleted haploidentical stem cell grafts.

Authors:  Sergio Rutella; Perla Filippini; Valentina Bertaina; Giuseppina Li Pira; Lidia Altomare; Stefano Ceccarelli; Letizia P Brescia; Barbarella Lucarelli; Elia Girolami; Gianpiero Conflitti; Maria Giuseppina Cefalo; Alice Bertaina; Tiziana Corsetti; Lorenzo Moretta; Franco Locatelli
Journal:  J Transl Med       Date:  2014-09-02       Impact factor: 5.531

10.  Role of DNA-LL37 complexes in the activation of plasmacytoid dendritic cells and monocytes in subjects with type 1 diabetes.

Authors:  Darshan Badal; Devi Dayal; Gunjan Singh; Naresh Sachdeva
Journal:  Sci Rep       Date:  2020-06-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.